Professional Documents
Culture Documents
com
Abstract
Objectives: Different forms of allogenic dentine have been studied for their potential use as bone substitutes. We report a new method for
processing bovine dentine that results in a sterile bioactive material for repair and regeneration of bone.
Methods: Extracted bovine dentine was processed mechanically and chemically with inorganic and organic solvents, and sterilised. The in
vitro biocompatibility on human gingival fibroblasts was assessed by the Alamar Blue assay and the in vivo biocompatibility evaluated by
implantation of the processed dentine into rats’ femurs.
Results: The dentine showed excellent biocompatibility in vitro, stimulated formation of new bone and was completely incorporated into the
new bone in vivo.
Significance: Processed bovine dentine has the potential to be used as a suitable substitute in bone repair and regeneration.
© 2007 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
0266-4356/$ – see front matter © 2007 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.bjoms.2007.07.209
K. Moharamzadeh et al. / British Journal of Oral and Maxillofacial Surgery 46 (2008) 110–113 111
Material and methods sutures and the animals allowed to recover. They were main-
tained for 4 weeks and then killed by cervical dislocation
Processing of dentine (schedule one method). The right femurs were dissected free
and placed in formalin before decalcification and processing
Extracted young bovine teeth with open apices were washed to haematoxylin and eosin stained paraffin sections.
with water, cleaned, and all soft tissues including the pulp and
periodontal ligament were removed from the root. After the
enamel had been removed with a high-speed diamond bur, Results
the dentine was broken into small pieces (5–10 mm) using
a mortar and pestle. After boiling the dentine fragments in In vitro test
distilled water for 2 h, they were refluxed in isopropanol for
During incubation, the colour of Alamar Blue changed from
2 h to remove any remaining soft tissue or fat. After they
blue to red. The presence of processed dentine did not inhibit
had been washed with distilled boiling water several times to
the chemical reduction of Alamar Blue. In fact, statistical
eliminate the organic solvent, the fragments were air dried at
analysis by one-way ANOVA showed that there was an
100 ◦ C. Final stages involved grinding pieces of dentine into
increase in the cell viability of the test group, mean (SD)
small particle powder using a high-speed mechanical blender,
being 284.1 (2.9) compared with 274.9 (7.0).
packaging, and sterilisation by ␥-irradiation.
Primary human gingival fibroblasts were obtained from Histological examination of the implanted dentine showed
stocks stored in liquid nitrogen. These cells had already complete incorporation of the particles of dentine into newly
been harvested from biopsy specimens from patients with formed bone (Fig. 1). There were no signs of chronic inflam-
Ethics Committee approval. The cells were cultured in mation, giant cells, or foreign body reactions to the implant
Dulbecco’s Modified Eagle Medium (Sigma, UK) supple- (Fig. 2). Numerous osteoblasts were found on the periphery
mented with 10% fetal calf serum (Biowest Ltd., UK), of the newly formed bone around the dentine. In some areas
l-glutamine (Sigma, UK) 2 mM, penicillin 100 U/ml (Sigma, dentine had been resorbed by the osteoclasts and replaced by
UK), and streptomycin 100 g/ml (Sigma, UK). Cultures new bone (Fig. 3).
were incubated at 37 ◦ C in a humidified atmosphere of 5%
carbon dioxide in air. In vitro biocompatibility of the graft
material was assessed by culturing human gingival fibrob- Discussion
lasts in the vicinity of the powder in cell culture inserts.
100,000 cells/well were seeded into 24-well plates, cultured Bovine dentine was successfully processed and sterilised in
for 24 h, and then exposed to dentine powder in cell cul- this study for the in vivo use as a bone substitute. By boiling
ture inserts for 72 h (n = 4). Cells with empty inserts were
used as controls. Cell viability was assessed by Alamar Blue
assay. After the incubation period the inserts and the medium
were removed and solution of 10% Alamar Blue (Biosource,
Camarilo, CA) in 1 ml Dulbecco’s Modified Eagles Medium
(DMEM) was added to each well. After 5 h incubation, 200 l
of each well were placed into 96-well plate in duplicates, and
the fluorescence intensity was measured using a fluorescent
plate reader (FLUOstar Galaxy, BMG Lab technologies) at
an excitation wavelength of 530 nm and emission wavelength
of 580 nm. Data were analysed by one-way ANOVA.
Six male rats aged 4–5 weeks, were used in the study. They
were housed together under standard laboratory conditions
and had free access to food and water. Samples of sterile
dentine were placed into a defect created in the mid-shaft of
the right femur under aseptic conditions. They were oper-
ated on under general anaesthesia, and a single bone defect Fig. 1. Histological examination of dentine implanted into the bone, showing
was created in the femur using a stainless steel dental bur with complete incorporation of the dentine particle into the newly formed bone
sterile saline irrigation; wounds were closed using resorbable (haematoxylin and eosin, original magnification ×40).
112 K. Moharamzadeh et al. / British Journal of Oral and Maxillofacial Surgery 46 (2008) 110–113
1. Geissler WB. Bone graft substitutes in the upper extremity. Hand Clin
2006;22:329–39.
2. Andersson L. Dentoalveolar ankylosis and associated root resorption in
replanted teeth. Experimental and clinical studies in monkeys and man.
Swed Dent J Suppl 1988;56:1–75.
3. Yoshida T, Itoh T, Saitoh T, Sekine I. Histopathological study of the
use of freeze-dried allogenic dentin powder and True Bone Ceramic as
apical barrier materials. J Endod 1998;24:581–6.
4. Fugazzotto PA, De Paoli S, Benfenati SP. The use of allogenic freeze-
dried dentin in the repair of periodontal osseous defects in humans.
Quintessence Int 1986;17:461–77.
5. Gomes MF, dos Anjos MJ, Nogueira Tde O, Catanzaro Guimaraes SA.
Autogenous demineralized dentin matrix for tissue engineering applica-
tions: radiographic and histomorphometric studies. Int J Oral Maxillofac
Implants 2002;17:488–97.
6. Gomes MF, dos Anjos MJ, Nogueira TO, Guimaraes SA. Histologic
evaluation of the osteoinductive property of autogenous demineralized
dentin matrix on surgical bone defects in rabbit skulls using human
amniotic membrane for guided bone regeneration. Int J Oral Maxillofac
Implants 2001;16:563–71.
7. Su-Gwan K, Hak-Kyun K, Sung-Chul L. Combined implantation of
particulate dentine, Plaster of Paris, and a bone xenograft (Bio-Oss)
Fig. 3. Dentine resorption and subsequently deposition of new bone by the for bone regeneration in rats. J Craniomaxillofac Surg 2001;29:282–
osteoblasts (haematoxylin and eosin, original magnification ×20). 8.
K. Moharamzadeh et al. / British Journal of Oral and Maxillofacial Surgery 46 (2008) 110–113 113
8. Nociari MM, Shalev A, Benias P, Russo C. A novel one-step, highly in the repair of experimental skull bone defects. J Oral Maxillofac Surg
sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J 1992;50:241–9.
Immunol Methods 1998;213:157–67. 12. Jensen SS, Aaboe M, Pinholt EM, Hjorting-Hansen E, Melsen F, Ruyter
9. Fields RD, Lancaster MV. Dual-attribute continuous monitoring of cell IE. Tissue reaction and material characteristics of four bone substitutes.
proliferation/cytotoxicity. Am Biotechnol Lab 1993;11:48–50. Int J Oral Maxillofac Implants 1996;11:55–66.
10. Lynch SE, Genco RJ, Marx RE, editors. Tissue engineering. Chicago: 13. Salata LA, Craig GT, Brook IM. Bone healing following the use of
Quintessence; 1999. hydroxyapatite or ionomeric bone substitutes alone or combined with a
11. Klinge B, Alberius P, Isaksson S, Jonsson J. Osseous response to guided bone regeneration technique: an animal study. Int J Oral Max-
implanted natural bone mineral and synthetic hydroxylapatite ceramic illofac Implants 1998;13:44–51.